Fig. 2: HCC EFTUD2 expression in HCC tissues predicts a poor prognosis in HCC patients.

a, b Overall survival (OS) and cumulative recurrence rate of cohort 1 (N = 126) and cohort 2 (N = 85) HCC patients based on EFTUD2 expression in tumor tissues, respectively.